Attachment III - Page 7 
RECOMBINANT DNA ADVISORY OOWITTEE 
WORKING GROUP CN REVISION OF TOE GUIDELINES 
NATIONAL INSmUTES OF HEALTH 
CHAIRMAN 
OCTIESMAN, SUSAN K., Ph.D. 
Senior Investigator 
Laboratory of Molecular Biology 
National Cancer Institute 
National Institutes of Health 
Bethesda, Marylemd 20205 
301 496-2095 
ADELBERG, EDWARD A. , Ph.D. 
Department of Hunan Genetics 
School of Medicine 
Yale Uhiversity 
New Haven, Connecticut 06510 
203 436-0821 
BEPNS, KEWETH I., Ph.D., M.D. 
Chairman 
Department of Inmunology 
and Medical Microbiology 
University of Florida 
College of Medicine 
Gainesville, Florida 32610 
904 392-3311 
GOLDSTEIN, RICHARD, Ph.D. 
Associate Professor 
Department of Microbiology 
and Molecular Genetics 
Harvard Medical School 
Boston, Massachusetts 02115 
617 732-1911 
HARRIS, JEAN L. , M.D. 
Secretary of Human Resources 
Commonwealth of Virginia 
Office of Governor 
Bost Office Box 1475 
Richmond, Virginia 23219 
804 786-7765 
KING, PATRICIA A., J.D. 
Georgetown University 
Law School 
600 New Jersey Avenue, N.W. 
Washington, D.C. 20001 
202 624-8213 
LEVINE, MYRCN M., M.D. 
Director 
Center for Vaccine Development 
Division of Infectious Diseases 
University of Maryland 
School of Medicine 
Beiltimore, Maryland 21201 
301 528-7588 
LEKIS, HERMAN W., Ph.D. 
Senior Scientist for 
Recombinant DNA 
Division of Physiology 
National Science Foundation 
Washington, D.C. 20550 
202 357-7647 
MASON, JAMES O. , M.D. , Dr. Ph. 
Executive Director 
Utah State Department of 
Health 
Bost Office Box 2500 
Salt Lake City, Utah 84113 
801 533-6111 
1237 ] 
